This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Scinopharm Taiwan, Ltd.. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: The Innovations of Wen-Li Shih
Introduction
Wen-Li Shih is a notable inventor based in Nantou, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the production of important compounds. With a total of 3 patents to his name, his work has had a considerable impact on the industry.
Latest Patents
Wen-Li Shih's latest patents include a process for the production of Fondaparinux sodium. This invention provides improved methods for preparing Fondaparinux sodium by converting a compound of formula ABCDE4 at a reaction pH of no more than about 9.0. Additionally, the invention includes intermediates for the synthesis of Fondaparinux sodium. Another significant patent is for the process of preparing enzalutamide, which outlines an efficient method for its preparation.
Career Highlights
Wen-Li Shih is currently associated with Scinopharm Taiwan, Ltd., where he continues to innovate and contribute to the pharmaceutical sector. His expertise in chemical processes has positioned him as a valuable asset in his field.
Collaborations
Wen-Li Shih has worked alongside talented colleagues, including Shang-Hong Chen and Yuan-Xiu Liao, who have contributed to his projects and research endeavors.
Conclusion
Wen-Li Shih's contributions to pharmaceutical innovations through his patents and collaborative efforts highlight his importance in the field. His work continues to influence the development of critical medications and processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile